Compounds > quadazocine
Page last updated: 2024-09-03

quadazocine and levorphanol

quadazocine has been researched along with levorphanol in 2 studies

Compound Research Comparison

Studies
(quadazocine)		Trials
(quadazocine)		Recent Studies (post-2010)
(quadazocine)		Studies
(levorphanol)		Trials
(levorphanol)		Recent Studies (post-2010) (levorphanol)
81006342618

Protein Interaction Comparison

ProteinTaxonomyquadazocine (IC50)levorphanol (IC50)
Solute carrier family 22 member 1 Homo sapiens (human)8
Glutamate receptor ionotropic, NMDA 2DHomo sapiens (human)2.6
Glutamate receptor ionotropic, NMDA 3BHomo sapiens (human)2.6
Mu-type opioid receptorHomo sapiens (human)0.0001
Glutamate receptor ionotropic, NMDA 1 Rattus norvegicus (Norway rat)4.45
Delta-type opioid receptorHomo sapiens (human)0.004
Kappa-type opioid receptorHomo sapiens (human)0.004
Mu-type opioid receptorCavia porcellus (domestic guinea pig)0.0006
Glutamate receptor ionotropic, NMDA 2A Rattus norvegicus (Norway rat)4.45
Glutamate receptor ionotropic, NMDA 2BRattus norvegicus (Norway rat)4.45
Glutamate receptor ionotropic, NMDA 2CRattus norvegicus (Norway rat)4.45
Glutamate receptor ionotropic, NMDA 1Homo sapiens (human)2.6
Glutamate receptor ionotropic, NMDA 2AHomo sapiens (human)2.6
Glutamate receptor ionotropic, NMDA 2BHomo sapiens (human)2.6
Glutamate receptor ionotropic, NMDA 2CHomo sapiens (human)2.6
Glutamate receptor ionotropic, NMDA 2DRattus norvegicus (Norway rat)4.45
Glutamate receptor ionotropic, NMDA 3AHomo sapiens (human)2.6
Glutamate receptor ionotropic, NMDA 3BRattus norvegicus (Norway rat)4.45
Glutamate receptor ionotropic, NMDA 3ARattus norvegicus (Norway rat)4.45

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Flitstein, A; Oppenheimer, E; Sarne, Y1
Bertalmio, AJ; Woods, JH1

Other Studies

2 other study(ies) available for quadazocine and levorphanol

ArticleYear
Anti-arrhythmic activities of opioid agonists and antagonists and their stereoisomers.
    British journal of pharmacology, 1991, Volume: 102, Issue:3

    Topics: Animals; Anti-Arrhythmia Agents; Azocines; Levorphanol; Male; Morphine; Naloxone; Narcotic Antagonists; Rats; Stereoisomerism

1991
Differentiation between mu and kappa receptor-mediated effects in opioid drug discrimination: apparent pA2 analysis.
    The Journal of pharmacology and experimental therapeutics, 1987, Volume: 243, Issue:2

    Topics: Alfentanil; Animals; Azocines; Codeine; Cyclazocine; Discrimination Learning; Dose-Response Relationship, Drug; Ethylketocyclazocine; Fentanyl; Levorphanol; Macaca mulatta; Male; Morphine; Receptors, Opioid; Receptors, Opioid, kappa; Receptors, Opioid, mu

1987